Lab Report Final 5206
Lab Report Final 5206
Index
Experiment no. : 01
1|Page
Ka = ¿ ¿ ………………………………………………….. (2)
Ka is equilibrium constant
pH = -log [H+] or, 10-pH = [H+] …………………………………… (3)
PKa= -log (Ka) or, 10-pka = Ka …………………………………… (4)
By substituting equations 3& 4into equation 2, we can derive the Handerson-Hasselbalch
equation -
10-pka = 10-pH [A-]/ [HA]
[HA]/ [A-] =10-pH /10-pka
[HA]/ [A-] = 10Pka-pH
[Acid] / [base] = 10pka-pH
(According to Handerson–Hasselbalch buffer relationship, pH, pka & buffer component
concentration for a weak acid)
Here, Acid = proton donor (HA)
Base = conjugate base (A-)
If the pka is greater than pH, there will be more of the acid form in the solution.
2|Page
If the pka is equal to the pH, there will be an equal amount of acid and base in solution.
If the pka is less than the pH, there will be more of the base form in the solution
Equipment:
pH meter
mixing paste & magnetic stir bar
100ml graduated cylinder
250 ml volumetric flask
250ml beaker
50 ml burette, burette clamp
Retort stand
Reagent preparation:
Preparing 250 ml of a 0.2M solution of sodium phosphate monobasic (SPM)
Step 1:
3|Page
Working procedure:
pH meter standardizing buffers (pH 7.4)
Part A: Preparing Sorensen’s buffer
Precaution:
4|Page
Proper safety concern should be maintained; such as hand gloves, mask apron etc.
Volume adjustment should be done carefully. Solution should not cross meniscus level
pH should be calibrated before taking the reading.
Careful measurement of pH.
Experiment no. : 02
Name of the experiment: Preparation of citro-phosphate buffer pH 4.5 at laboratory.
Objectives:
To understand the nature of buffer solution.
To learn how to prepare buffer.
Principle:
Buffer solution is an aqueous solution of a weak acid and its conjugate base or vice versa which
has the capacity of showing resistance in pH change. Its pH change is very little; actually
negligible when small amount of acid or base is added. The main significance of buffer solution
is to maintain a certain pH of formulation.
Buffer solutions are of two types-
1. Acidic buffer: acidic buffer is the buffer solution having pH less than 7 and consist of a
weak acid and its one of salt. Examples ; a mixture of ethanoic acid and sodium ethanoate
in solution
The basic principle of preparing citro-phosphate buffer includes preparing a solution of weak
citric acid and salt disodium hydrogen orthophosphate in distilled water which is followed by pH
adjustment to 4.5 by using weak citric acid or NaOH base.
Materials and reagent
Materials:
a) 1000ml beaker
b) 1000ml volumetric flask
c) weight balance
d) pH meter
e) spatula
f) glass rod
Reagent:
1. Di-sodium hydrogen ortho-phosphate (Na2HPO4.2H2O)
2. Citric acid
3. Distilled water
4. NaOH solution (0.1 M)
Reagent preparation:
Follow rules given in experiment one to prepare the molar solution.
Procedure:
According to British Pharmacopeia-
prepare 800 ml of distilled water in a 1000 ml of volumetric flask
18.15gm of disodium hydrogen orthophosphate is added to the water with stirring
9.336gm of citric acid is added to the solution & stir until dissolve
Final solution volume is adjusted to 1000ml with distilled water
pH is measured by a pH meter & adjusted to pH 4.5 with addition of citric acid solution
(0.1M)
Calculation: 50 ml 0.1 M citric acid solution is prepared 0.96gm citric acid is required which is
calculated by following-
Molecular weight of citric acid = 192.124gm
Now, 1000ml 1M citric acid contains 192.124gm
6|Page
Experiment no. : 03
Experiment Name: Dissolution testing of Ibuprofen tablet.
Principle:
Dissolution is pharmaceutically defined as the rate of mass transfer from a solid surface into the
dissolution medium or solvent under standardized conditions of liquid/solid interface,
temperature and solvent composition. It is a dynamic property that changes with time and
explains the process by which a homogenous mixture of a solid or a liquid can be obtained in a
solvent.
In the pharmaceutical industry, drug dissolution testing is routinely used to provide critical in
vitro drug release information for both quality control purposes, to assess batch-to-batch
consistency of solid oral dosage forms such as tablets, and drug development to predict in vivo
drug release profiles. In vitro drug dissolution data generated from dissolution testing
experiments can be related to in vivo pharmacokinetic data by means of in vitro-in vivo
correlations (IVIVC). A well- established predictive IVIVC model can be very helpful for drug
formulation design and post- approval manufacturing changes.
The main objective of developing and evaluating an IVIVC is to establish the dissolution test as
a surrogate for human bioequivalence studies, as stated by the Food and Drug Administration.
Analytical data from drug dissolution testing are sufficient in many cases to establish safety and
efficacy of a drug product without in vivo tests, the dissolution testing which is conducted in
7|Page
dissolution apparatus must be able to provide accurate and reproductive results. Several
dissolution apparatuses exist. In United States Pharmacopeia (USP), there are four dissolution
apparatus standardized and specified they are:
1. USP Dissolution Apparatus 1 - Basket (37°C)
2. USP Dissolution Apparatus 2 - Paddle (37°C)
3. USP Dissolution Apparatus 3 - Reciprocating Cylinder (37°C)
4. USP Dissolution Apparatus 4 - Flow-Through Cell (37°C)
5. USP Dissolution Apparatus 2 is the most widely used apparatus among these
four.
Ibuprofen tablet is a painkiller. It is more potent than aspirin and paracetamol. It has anti-
inflammatory and anti- platelet action also. It is a potent inhibitors of cyclooxygenase. If onset of
action is 30 minutes and chemical formula is C13H18O2.It is a drug of NSAIDs class.
Apparatus:
● Dissolution tester with paddle.
● Beaker 100 ml
● Volumetric flask
● Glass rod
● UV-Spectrometer
Chemical Ingredient:
1. Ibuprofen tablet (Flamex 400mg)
2. Distilled water
3. Buffer solution
4. Standard Ibuprofen solution (Profen 400mg)
Procedure:
8|Page
Precaution:
9|Page
Experiment no. : 04
Principle:
Dissolution is pharmaceutically defined as the rate of mass transfer from a solid surface into the
dissolution medium or solvent under standardized conditions of liquid/solid interface,
temperature and solvent composition. It is a dynamic property that changes with time and
explains the process by which a homogenous mixture of a solid or a liquid can be obtained in a
solvent.
In the pharmaceutical industry, drug dissolution testing is routinely used to provide critical in
vitro drug release information for both quality control purposes, to assess batch-to-batch
consistency of solid oral dosage forms such as tablets, and drug development to predict in vivo
drug release profiles. In vitro drug dissolution data generated from dissolution testing
experiments can be related to in vivo pharmacokinetic data by means of in vitro-in vivo
correlations (IVIVC). A well- established predictive IVIVC model can be very helpful for drug
formulation design and post- approval manufacturing changes.
The main objective of developing and evaluating an IVIVC is to establish the dissolution test as
a surrogate for human bioequivalence studies, as stated by the Food and Drug Administration.
Analytical data from drug dissolution testing are sufficient in many cases to establish safety and
efficacy of a drug product without in vivo tests, the dissolution testing which is conducted in
dissolution apparatus must be able to provide accurate and reproductive results. Several
10 | P a g e
dissolution apparatuses exist. In United States Pharmacopeia (USP), there are four dissolution
apparatus standardized and specified they are:
Apparatus:
● Dissolution tester.
● Beaker 100 ml
● Volumetric flask
● Glass rod
● UV-Spectrometer
Chemical Ingredient:
Procedure:
Preparation of buffer solution:
● 28.80 g of disodium hydrogen orthophosphate is weighted.
● 11.45 g of potassium dihydrogen orthophosphate is weighted.
● They are mixed in sufficient amount of water to create a clear solution of phosphate
buffer.
● Then their PH is measured to be 6.8 according to British pharmacopeia.
11 | P a g e
Precaution:
Disodium hydrogen orthophosphate & potassium dihydrogen phosphate should be
handled carefully
pH buffer solution should be accurate
Dissolution tester should be carefully handled
Temperature & paddle rotation should be carefully settled
We should wear protective wear during this whole procedure